These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23871750)

  • 1. Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems.
    Mackowick KM; Barr MS; Wing VC; Rabin RA; Ouellet-Plamondon C; George TP
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():79-85. PubMed ID: 23871750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.
    Parikh V; Kutlu MG; Gould TJ
    Schizophr Res; 2016 Mar; 171(1-3):1-15. PubMed ID: 26803692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.
    Sacco KA; Termine A; Seyal A; Dudas MM; Vessicchio JC; Krishnan-Sarin S; Jatlow PI; Wexler BE; George TP
    Arch Gen Psychiatry; 2005 Jun; 62(6):649-59. PubMed ID: 15939842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.
    Dalack GW; Healy DJ; Meador-Woodruff JH
    Am J Psychiatry; 1998 Nov; 155(11):1490-501. PubMed ID: 9812108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between nicotine dependence and the endophenotype-related trait of cognitive function but not acoustic startle reponses in Japanese patients with schizophrenia.
    Kishi T; Fukuo Y; Okochi T; Kawashima K; Moriwaki M; Furukawa O; Musso GM; Fujita K; Correll CU; Iwata N
    Hum Psychopharmacol; 2013 May; 28(3):220-9. PubMed ID: 23553665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.
    D'Souza MS; Markou A
    Neuropharmacology; 2012 Mar; 62(3):1564-73. PubMed ID: 21288470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma.
    Phillips JM; Ehrlichman RS; Siegel SJ
    Neuroscience; 2007 Feb; 144(4):1314-23. PubMed ID: 17184927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia.
    Wing VC; Wass CE; Soh DW; George TP
    Ann N Y Acad Sci; 2012 Feb; 1248():89-106. PubMed ID: 22129082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine dependence and psychiatric disorders.
    Salín-Pascual RJ; Alcocer-Castillejos NV; Alejo-Galarza G
    Rev Invest Clin; 2003; 55(6):677-93. PubMed ID: 15011738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.
    Weinberger AH; Sacco KA; Creeden CL; Vessicchio JC; Jatlow PI; George TP
    Schizophr Res; 2007 Mar; 91(1-3):217-25. PubMed ID: 17293085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia.
    Moss TG; Sacco KA; Allen TM; Weinberger AH; Vessicchio JC; George TP
    Drug Alcohol Depend; 2009 Sep; 104(1-2):94-9. PubMed ID: 19447570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Electronic Cigarettes Leads to Significant Beta2-Nicotinic Acetylcholine Receptor Occupancy: Evidence From a PET Imaging Study.
    Baldassarri SR; Hillmer AT; Anderson JM; Jatlow P; Nabulsi N; Labaree D; Cosgrove KP; O'Malley SS; Eissenberg T; Krishnan-Sarin S; Esterlis I
    Nicotine Tob Res; 2018 Mar; 20(4):425-433. PubMed ID: 28460123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research.
    Portugal GS; Gould TJ
    Behav Brain Res; 2008 Nov; 193(1):1-16. PubMed ID: 18571741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
    D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
    Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms.
    George TP; Termine A; Sacco KA; Allen TM; Reutenauer E; Vessicchio JC; Duncan EJ
    Schizophr Res; 2006 Oct; 87(1-3):307-15. PubMed ID: 16854565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction.
    Wittenberg RE; Wolfman SL; De Biasi M; Dani JA
    Neuropharmacology; 2020 Oct; 177():108256. PubMed ID: 32738308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.
    Hong LE; Thaker GK; McMahon RP; Summerfelt A; Rachbeisel J; Fuller RL; Wonodi I; Buchanan RW; Myers C; Heishman SJ; Yang J; Nye A
    Arch Gen Psychiatry; 2011 Dec; 68(12):1195-206. PubMed ID: 21810630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review on the Receptor-ligand Molecular Interactions in the Nicotinic Receptor Signaling Systems.
    Liu W; Su K
    Pak J Biol Sci; 2018; 21(2):51-66. PubMed ID: 30221881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study.
    McKee SA; Weinberger AH; Harrison EL; Coppola S; George TP
    Schizophr Res; 2009 Dec; 115(2-3):317-24. PubMed ID: 19700263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinic receptors and stages of nicotine dependence.
    Brennan KA; Lea RA; Fitzmaurice PS; Truman P
    J Psychopharmacol; 2010 Jun; 24(6):793-808. PubMed ID: 19251827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.